Navigation Links
AspenBio Pharma Announces Pricing of Public Offering of 1,476,000 Shares of Common Stock
Date:11/14/2012

ward-looking statements as a result of many factors, including our ability to successfully complete required product development and modifications in a timely and cost effective manner, complete clinical trial activities for AppyScore required for FDA submission, obtain FDA clearance or approval, complete and obtain CE Mark, cost effectively manufacture and generate revenues from AppyScore, execute agreements required to successfully advance the company's objectives, retain the management team to advance the products, overcome adverse changes in market conditions and the regulatory environment, obtain and enforce intellectual property rights, and realize value of intangible assets. Furthermore, AspenBio does not intend (and is not obligated) to update publicly any forward-looking statements. The contents of this press release should be considered in conjunction with the risk factors contained in AspenBio's recent filings with the SEC, including its Form 10-Q for the period ended September 30, 2012, filed on November 7, 2012.


For Investors & Media:
Joshua Drumm, Ph.D. / Jason Rando
Tiberend Strategic Advisors, Inc.
(212) 827-0020
jdrumm@tiberend.com
jrando@tiberend.com


'/>"/>
SOURCE AspenBio Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AspenBio Pharma Engages Tiberend Strategic Advisors as Investor and Public Relations Agency of Record
2. AspenBio Pharma Executes Worldwide License Agreement for its Animal Health Assets
3. AspenBio Pharma to Provide Shareholders with Business Update
4. AspenBio Pharma Begins Training Hospital Sites for Pivotal Clinical Trial
5. AspenBio Pharma Announces Proposed Public Offering
6. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
7. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
8. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
9. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
10. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
11. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 6, 2015  Impax Laboratories, Inc. (NASDAQ: IPXL ... has resigned from the Company,s Board of Directors in ... a co-founder of Impax in 1995 and served as ... 2006 until April 2014. Logo - http://photos.prnewswire.com/prnh/20150310/180590LOGO ... President and Chief Executive Officer stated, "We wish to ...
(Date:7/6/2015)... BOSTON , July 6, 2015 ... Inc. (NASDAQ: ISIS ), announced today that ... Orphan Drug Designation to volanesorsen (ISIS-APOCIII Rx ) ... Syndrome (FCS).  FCS is a rare genetic disease ... of pancreatitis. In a Phase 2 study published ...
(Date:7/6/2015)... 6, 2015 /PRNewswire/ -- China Nepstar Chain Drugstore Ltd. (NYSE: ... retail drugstore chain in China ... announced that its board of directors has received a ... Simin Zhang , chairman of the board of ... Ltd., an investment vehicle wholly owned by Mr. Zhang(" ...
Breaking Medicine Technology:Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 2Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 3Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 4Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 2China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 3China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 4China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 5China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 6
... Mass., Oct. 20, 2011 Boston Scientific Corporation (NYSE: ... 30, 2011, as well as updated sales and earnings per share ... Third quarter and other highlights: ... per share and adjusted EPS of $0.15, both exceeding previous guidance ...
... 20, 2011 OncoSec Medical Incorporated (OTCBB: ONCS), which ... treatment of solid tumor cancers, announced today the submission ... Food and Drug Administration (FDA) for its patented ... generator and hand-held applicator. The Company has been developing ...
Cached Medicine Technology:Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 2Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 3Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 4Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 5Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 6Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 7Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 8Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 9Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 10Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 11Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 12Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 13Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 14Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 15Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 16Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 17Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 18Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 19Device Master File for OncoSec Medical System Completed and Submitted to FDA 2Device Master File for OncoSec Medical System Completed and Submitted to FDA 3
(Date:7/6/2015)... ... July 06, 2015 , ... Cancer Hope Network (CHN) has ... medical professionals to chat with the CHN patient services team and connect with ... diagnosis is often the most traumatic experience of a person’s life,” said CHN ...
(Date:7/6/2015)... ... July 06, 2015 , ... MD Now, the leading and fastest-growing ... newly constructed urgent care center will serve residents and visitors in the Cutler Bay ... MD Now’s 22nd South Florida location, the new facility will be the fourth to ...
(Date:7/6/2015)... ... July 06, 2015 , ... World renowned Los Angeles facial plastic surgeon ... appearance through comprehensive treatment solutions. Individuals that want to make multiple changes to their ... plan that resolves each of their needs. , "Anytime I see an opportunity ...
(Date:7/6/2015)... London, United Kingdom (PRWEB) , ... July 06, 2015 , ... ... Guide app could help. More than 29 million Americans have diabetes, the majority of ... addition, 86 million U.S. adults or more than one in three, have prediabetes (abnormally ...
(Date:7/5/2015)... ... July 06, 2015 , ... City Sports, the Boston-based specialty sporting goods retailer, ... clinics for first-time triathletes this summer with ethos, the owner and operator of the ... 9, at 6:00 p.m. at the North End Greenway. The event will help new ...
Breaking Medicine News(10 mins):Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Los Angeles Plastic Surgeon, Dr. Paul Nassif, is Now Offering Comprehensive Facial Plastic Surgery Procedures 2Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 3
... vaccine called the TAT vaccine has been developed in Italy ... And more importantly it has had a 71% success rate ... human testing and this may be the brightest hope for ... the Department of Virology at Italy’s National Health Institute and ...
... Allergy and asthma patients can now breathe easy. Literally. A ... be effective in improving the quality of life and has ... findings of this study are reported in the latest issue ... M. Walker, PhD, of the Imperial College School of Medicine ...
... the importance of sleep for memory and learning. It ... as fatigue and reduced alertness. ,A study ... allowing recovery sleep by Harvard Medical school researches. Subjects ... no improvement in task performance but those who were ...
... Have you ever wondered why your kids are so aggressive and ... over there is increasing concern over the way the children of ... looking for help. Things are no better in India. With the ... all at a very young age and many parents complain that ...
... researchers at the just concluded Indian science congress in New ... to combat anemia with iron fortification of crops. Almost 50% ... are anemic in India. While iron supplementation is expensive, fortification ... fight anemia in people is fairly cheaper, scientists say. ...
... pregnancy can lead to increased risk of heart problems ... environment contribute to several aspects of cardiovascular risks in ... ,People whose mothers starved during the first 13 ... their adult life, Starvation during mid or late pregnancy ...
Cached Medicine News:
The ImagingPlanet 55 mm surgical microscope video adapter: superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Leica surgical ...
The ImagingPlanet 55 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical micro...
Introducing Optronics DVMR, the first digital surgical documentation system designed for the microsurgical operating room environment. DVMR accepts images from a variety of high-resolution cameras fo...
Research Grade Microscope Camera from ImagingPlanet Research Microscopy Group, a superior imaging technology that delivers increased image resolution and precise color accuracy at an affordable pric...
Medicine Products: